ATE278706T1 - Verfahren zur konzentrierung von unlöslichen protein mittels filtration mit schwingenden membranen - Google Patents

Verfahren zur konzentrierung von unlöslichen protein mittels filtration mit schwingenden membranen

Info

Publication number
ATE278706T1
ATE278706T1 AT02704642T AT02704642T ATE278706T1 AT E278706 T1 ATE278706 T1 AT E278706T1 AT 02704642 T AT02704642 T AT 02704642T AT 02704642 T AT02704642 T AT 02704642T AT E278706 T1 ATE278706 T1 AT E278706T1
Authority
AT
Austria
Prior art keywords
insoluble protein
vibrating membranes
membranes filtration
concentrating
concentrating insoluble
Prior art date
Application number
AT02704642T
Other languages
English (en)
Inventor
Benoit Champluvier
Philippe Jean Gervais Permanne
S A Biologicals
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE278706T1 publication Critical patent/ATE278706T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/147—Microfiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/16—Feed pretreatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/16—Rotary, reciprocated or vibrated modules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/04—Specific process operations in the feed stream; Feed pretreatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Water Supply & Treatment (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
AT02704642T 2001-01-09 2002-01-07 Verfahren zur konzentrierung von unlöslichen protein mittels filtration mit schwingenden membranen ATE278706T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0100513.1A GB0100513D0 (en) 2001-01-09 2001-01-09 Process
PCT/EP2002/000063 WO2002055539A1 (en) 2001-01-09 2002-01-07 Process to concentrate insoluble proteins by vibrating membrane filtration

Publications (1)

Publication Number Publication Date
ATE278706T1 true ATE278706T1 (de) 2004-10-15

Family

ID=9906486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02704642T ATE278706T1 (de) 2001-01-09 2002-01-07 Verfahren zur konzentrierung von unlöslichen protein mittels filtration mit schwingenden membranen

Country Status (9)

Country Link
US (1) US6939697B2 (de)
EP (1) EP1349868B1 (de)
JP (1) JP4074519B2 (de)
AT (1) ATE278706T1 (de)
CA (1) CA2433689A1 (de)
DE (1) DE60201496T2 (de)
ES (1) ES2229091T3 (de)
GB (1) GB0100513D0 (de)
WO (1) WO2002055539A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008027861A1 (en) * 2006-08-30 2008-03-06 Ge Healthcare Bio-Sciences Corp. System and method for characterizing membranes and membrane filtration devices
AU2008217189B2 (en) * 2007-02-22 2013-06-13 Baxalta GmbH Method of purification of hydrophobic proteins
US8546127B2 (en) * 2008-06-30 2013-10-01 General Electric Company Bacteria/RNA extraction device
US8158405B2 (en) * 2008-06-30 2012-04-17 General Electric Company Process for concentrating and processing fluid samples
DE102009010484A1 (de) * 2009-02-25 2010-08-26 Gea Westfalia Separator Gmbh Filtrationsverfahren und -vorrichtung
AU2011246021B2 (en) 2010-04-30 2014-03-13 Asahi Kasei Pharma Corporation High-purity soluble thrombomodulin and method for producing same
US9475709B2 (en) 2010-08-25 2016-10-25 Lockheed Martin Corporation Perforated graphene deionization or desalination
US9028663B2 (en) 2012-03-21 2015-05-12 Lockheed Martin Corporation Molecular separation device
US20130277305A1 (en) * 2012-04-19 2013-10-24 Lockheed Martin Corporation Selectively perforated graphene membranes for compound harvest, capture and retention
US9834809B2 (en) 2014-02-28 2017-12-05 Lockheed Martin Corporation Syringe for obtaining nano-sized materials for selective assays and related methods of use
US9610546B2 (en) 2014-03-12 2017-04-04 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US10653824B2 (en) 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
US10017852B2 (en) 2016-04-14 2018-07-10 Lockheed Martin Corporation Method for treating graphene sheets for large-scale transfer using free-float method
US10376845B2 (en) 2016-04-14 2019-08-13 Lockheed Martin Corporation Membranes with tunable selectivity
US9744617B2 (en) 2014-01-31 2017-08-29 Lockheed Martin Corporation Methods for perforating multi-layer graphene through ion bombardment
TW201504140A (zh) 2013-03-12 2015-02-01 Lockheed Corp 形成具有均勻孔尺寸之多孔石墨烯之方法
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
KR20160142820A (ko) 2014-01-31 2016-12-13 록히드 마틴 코포레이션 브로드 이온 필드를 사용한 2차원 물질 천공
CA2938305A1 (en) 2014-01-31 2015-08-06 Lockheed Martin Corporation Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
AU2015229331A1 (en) 2014-03-12 2016-10-27 Lockheed Martin Corporation Separation membranes formed from perforated graphene
SG11201701654UA (en) 2014-09-02 2017-04-27 Lockheed Corp Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same
AU2016303048A1 (en) 2015-08-05 2018-03-01 Lockheed Martin Corporation Perforatable sheets of graphene-based material
WO2017023377A1 (en) 2015-08-06 2017-02-09 Lockheed Martin Corporation Nanoparticle modification and perforation of graphene
WO2017180134A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
WO2017180139A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Two-dimensional membrane structures having flow passages
SG11201809016QA (en) 2016-04-14 2018-11-29 Lockheed Corp Selective interfacial mitigation of graphene defects
KR20180133430A (ko) 2016-04-14 2018-12-14 록히드 마틴 코포레이션 결함 형성 또는 힐링의 인 시츄 모니터링 및 제어를 위한 방법
WO2018185048A1 (en) * 2017-04-03 2018-10-11 Novozymes A/S Recovery process

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900449A (en) * 1987-05-20 1990-02-13 Gelman Sciences Filtration membranes and method of making the same
US4872988A (en) * 1988-02-02 1989-10-10 Culkin Joseph B Method and device for separation of colloidal suspensions
US4952317A (en) 1989-03-10 1990-08-28 Bradley Culkin Device and method for filtering a colloidal suspension
US5468844A (en) 1994-01-07 1995-11-21 Protose Technologies Inc. Process for the membrane-filtering of protein solutions
US5911880A (en) 1995-12-15 1999-06-15 Research Corporation Technologies, Inc. Self-wetting membranes from engineering plastics
ATE346676T1 (de) 1996-09-06 2006-12-15 Pall Corp Scherkraft trennverfahren und vorrichtung

Also Published As

Publication number Publication date
JP2004532183A (ja) 2004-10-21
EP1349868B1 (de) 2004-10-06
US6939697B2 (en) 2005-09-06
JP4074519B2 (ja) 2008-04-09
GB0100513D0 (en) 2001-02-21
US20040072314A1 (en) 2004-04-15
ES2229091T3 (es) 2005-04-16
CA2433689A1 (en) 2002-07-18
EP1349868A1 (de) 2003-10-08
WO2002055539A1 (en) 2002-07-18
DE60201496D1 (de) 2004-11-11
DE60201496T2 (de) 2006-03-09

Similar Documents

Publication Publication Date Title
ATE278706T1 (de) Verfahren zur konzentrierung von unlöslichen protein mittels filtration mit schwingenden membranen
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
ATE445642T1 (de) Trennung von polypeptiden mit einer racemisierten aminosäure
ATE318146T1 (de) Verfahren zur aufkonzentrierung von antikörperlösungen
ATE312120T1 (de) Verfahren zur herstellung von konzentrierten menschlichen immunoglobulinen für die therapeutische verwendung
ATE384742T1 (de) Verfahren zur reinigung von preproinsulin
DE60143325D1 (de) Verfahren zur Analyse von Proteinen durch isoelektrische Fokussierung einer Lösung
DE69829930D1 (de) Verfahren zur konzentrierung wässriger fluorpolymerdispersionen
DE602005021485D1 (de) Verfahren und zusammensetzungen mit molkeproteinisolaten
DE59601822D1 (de) Verfahren zur herstellung von weizenproteinhydrolysaten
DE59402684D1 (de) Verfahren zur partiellen modifizierung von porösen, hydrophilen filtermembranen
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
ATE245192T1 (de) Verfahren zur herstellung von gereinigten papillomavirus proteinen
DE10082576D2 (de) Verfahren zur Herstellung eines Kanalbildenden Proteins
ATE242816T1 (de) Verfahren zur reinigung von hyaluronsäure mit hohem molekulargewicht
ATE416619T1 (de) Verfahren zur dearomatisierung von molkeprotein
ATE417056T1 (de) Verfahren zur proteinreinigung
DK1105508T3 (da) Fremgangsmåde til oprensning af biomolekyle- eller proteinkomplekser
DE69523271D1 (de) Verfahren zur Pufferung von konzentrierten wässerigen Aufschlämmungen
ATE291230T1 (de) Verwendung von methoden zur identifizierung von hydrophilen signal-oligopeptiden
DE50311487D1 (de) Verfahren zur Herstellung von Kompositmembranen
DE60234430D1 (de) Halbdurchlässige verbundmembran, verfahren zur herstellung derselben und verfahren zur wasserbehandlung unter verwendung derselben
DE50100607D1 (de) Verfahren zur herstellung von n-(phosphonomethyl)glycin
DE50002849D1 (de) Verfahren zur aufkonzentrierung von dünnsäure
DE69811677D1 (de) Verfahren zur präparation von enantiomer-angereicherten, n-derivatisierten laktamen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties